2,189 results on '"Stuart, A."'
Search Results
2. Reply by Authors
3. MP34-07 ASSOCIATIONS BETWEEN UNMET SOCIAL NEEDS IN WOMEN WITH URINARY INCONTINENCE IN RURAL AND NON-RURAL AREAS
4. V10-02 IMMEDIATE AND LONG-TERM OUTCOMES OF 3-INCISION ARTIFICIAL URINARY SPHINCTER PLACEMENT: CAN A THIRD INCISION REDUCE COMPLICATIONS RELATED TO THE PRESSURE REGULATING BALLOON AND PUMP?
5. PD29-07 THE ROLE OF ETHNICITY IN SHAPING PROSTATE CANCER TREATMENT TRENDS AND IMPACTING OUTCOMES: A STUDY ON ASIAN SUBPOPULATIONS
6. MP34-12 ASSESSMENT OF URINARY SYMPTOMS IN TRANSGENDER, NON-BINARY AND GENDER NONCONFORMING INDIVIDUALS
7. MP17-04 TRENDS IN CHIEF RESIDENT CASE LOGS VERSUS SUBSEQUENT CASE LOG DATA IN CLINICAL PRACTICE
8. PD04-06 EXPERT CONSENSUS ON PEDIATRIC URODYNAMICS REPORTING USING MODIFIED DELPHI TECHNIQUE
9. PD61-02 RACIAL DIFFERENCES IN RECOMMENDATION AGAINST PROSTATE CANCER SURGERY IN THE UNITED STATES: A REGISTRY-BASED COMPARATIVE ANALYSIS
10. MP23-15 DUAL INCONTINENCE NEGATIVELY IMPACTS PSYCHOSOCIAL BURDEN AS ASSESSED BY PATIENT REPORTED OUTCOMES
11. PD19-02 THE ASSOCIATION OF COUNTY-LEVEL PROSTATE-SPECIFIC ANTIGEN SCREENING WITH METASTATIC PROSTATE CANCER AND PROSTATE CANCER MORTALITY
12. HF01-18 FORTUNE OF FORESIGHT: THE EVOLUTION OF PEDIATRIC UROLOGY AT BOSTON CHILDREN’S HOSPITAL (BCH)
13. PD10-04 PROSPECTIVE, RANDOMIZED STUDY OF STEERABLE URETEROSCOPIC RENAL EVACUATION VS URETEROSCOPY WITH BASKETING: 30-DAY RESULTS OF THE ASPIRE STUDY
14. MP35-04 SMOKING CHARACTERISTICS AND YEARS SINCE QUITTING SMOKING OF US ADULTS WITH LUNG AND BLADDER CANCER
15. MP34-08 SOCIAL VULNERABILITY AMONG WOMEN WITH URINARY INCONTINENCE CORRELATES TO MORE SEVERE URINARY SYMPTOMS AND WORSE QUALITY OF LIFE
16. MP68-04 ESTIMATING THE IMPACT OF ENHANCED CARE AT MINORITY-SERVING HOSPITALS ON DISPARITIES IN THE TREATMENT OF PROSTATE CANCER
17. PD52-04 ORAL TESTOSTERONE UNDECANOATE (316 MG BID) QUICKLY AND EFFECTIVELY INCREASES SERUM TESTOSTERONE CONCENTRATIONS IN HYPOGONADAL MEN
18. MP20-20 Outcomes Following Robotic-Assisted Simple Prostatectomy in Patients on Active Surveillance/Watchful Waiting or with Incidental Prostate Cancer Diagnosis on Pathology
19. The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder
20. Evaluation of Outcomes following Focal Ablative Therapy for Treatment of Localised Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-year Experience.
21. PD15-09 REAL WORLD ASSESSMENT OF MRI PREDICTORS OF RECTAL COMPLICATIONS FOLLOWING TRANSPERINEAL SPACEOAR HYDROGEL INSERTION
22. MP48-13 RURALITY IS ASSOCIATED WITH THE PRESENCE OF URINARY INCONTINENCE IN WOMEN
23. MP79-10 PHARMACOVIGILANCE ANALYSIS OF MELANOMA ADVERSE EVENTS IN MEN TREATED WITH SILDENAFIL FOR ERECTILE DYSFUNCTION
24. MP77-17 EFFECT OF TYPE OF DEFINITIVE TREATMENT ON RACE-BASED DIFFERENCES IN PROSTATE CANCER-SPECIFIC SURVIVAL
25. MP61-16 INITIAL CLINICAL TRIAL OF FOCAL LASER ABLATION UTILISING PROFOCAL-R® FOR LOCALISED PROSTATE CANCER
26. MP77-09 CHANGES IN PROSTATE SPECIFIC ANTIGEN UNITED STATES PREVENTIVE SERVICES TASK FORCE GUIDELINES AND THROUGH THE COVID-19 PANDEMIC
27. MP73-08 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: A 10 YEAR EXPERIENCE OF ONCOLOGICAL AND SAFETY OUTCOMES IN 276 PATIENTS
28. MP01-11 IN VITRO PROPAGATION OF UNDIFFERENTIATED SPERMATOGONIA ISOLATED FROM A 46, XX MALE TESTIS
29. MP73-11 MEDIUM TERM OUTCOMES FOLLOWING PRIMARY FOCAL CRYOTHERAPY FOR LOCALISED PROSTATE CANCER IN 323 PATIENTS, A MULTI-INSTITUTIONAL OBSERVATIONAL STUDY OVER 10 YEARS
30. MP34-01 UTI KNOWLEDGE ASSESSMENT AND ACQUISITION FOR URINARY TRACT INFECTIONS AMONG ADULT WOMEN
31. MP39-05 PREDICTORS OF FINANCIAL TOXICITY AMONG UNITED STATES PROSTATE CANCER SURVIVORS: RESULTS FROM A NATIONAL SURVEY
32. MP39-14 THE RISK OF CATASTROPHIC HEALTHCARE EXPENDITURES AMONG PROSTATE AND BLADDER CANCER SURVIVORS IN THE UNITED STATES
33. MP60-02 ATP2C1 IS A CANDIDATE FOR INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
34. MP12-10 THE EFFECT OF LIMITED ENGLISH PROFICIENCY ON PSA SCREENING RATES IN AMERICAN MEN
35. PD35-02 RETROSPECTIVE MULTICENTER ANALYSIS OF LONG-TERM OUTCOMES AFTER ARTIFICIAL URINARY SPHINCTER FOLLOWING URETHROPLASTY
36. LBA03-07 IMPERIAL PROSTATE-4 COMPARATIVE HEALTHCARE RESEARCH OUTCOMES OF NOVEL SURGERY IN PROSTATE CANCER (IP4-CHRONOS): EARLY FEASIBILITY, SAFETY AND FUNCTIONAL OUTCOMES FROM A PILOT RCT
37. MP43-11 EIGHT-YEAR FERTILITY PRESERVATION PROGRAM AT ATRIUM HEALTH WAKE FOREST BAPTIST FOCUSING ON SPERMATOGONIAL STEM CELL AND ROUND SPERMATID TECHNOLOGIES.
38. MP72-19 DECREASED UTILIZATION OF LOW-VALUE HEALTH CARE SERVICES DURING THE COVID-19 PANDEMIC
39. MP23-14 URETEROSCOPY WITH CVAC ASPIRATION SYSTEM FOR THE SURGICAL MANAGEMENT OF LARGE RENAL STONES
40. MP43-02 COMBINATION OF MICROSCOPIC TESTICULAR SPERM EXTRACTION (MTESE) AND DENSITY GRADIENT PROCESSING TO OPTIMIZE SPERM RETRIEVAL AND PREGNANCY OUTCOMES IN MEN WITH NONOBSTRUCTIVE AZOOSPERMIA (NOA)
41. MP80-17 RACIAL DIFFERENCES IN PATIENT-REPORTED OUTCOMES AMONG MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER
42. MP51-15 TEMPORARILY IMPLANTED NITINOL DEVICE VERSUS PROSTATIC URETHRAL LIFT FOR MINIMALLY INVASIVE SURGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOMS: A MATCHING-ADJUSTED INDIRECT COMPARISON
43. Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience
44. MP12-10 THE EFFECT OF LIMITED ENGLISH PROFICIENCY ON PSA SCREENING RATES IN AMERICAN MEN
45. MP72-19 DECREASED UTILIZATION OF LOW-VALUE HEALTH CARE SERVICES DURING THE COVID-19 PANDEMIC
46. MP01-11 IN VITRO PROPAGATION OF UNDIFFERENTIATED SPERMATOGONIA ISOLATED FROM A 46, XX MALE TESTIS
47. MP73-08 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: A 10 YEAR EXPERIENCE OF ONCOLOGICAL AND SAFETY OUTCOMES IN 276 PATIENTS
48. MP80-17 RACIAL DIFFERENCES IN PATIENT-REPORTED OUTCOMES AMONG MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER
49. MP51-15 TEMPORARILY IMPLANTED NITINOL DEVICE VERSUS PROSTATIC URETHRAL LIFT FOR MINIMALLY INVASIVE SURGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOMS: A MATCHING-ADJUSTED INDIRECT COMPARISON
50. MP39-05 PREDICTORS OF FINANCIAL TOXICITY AMONG UNITED STATES PROSTATE CANCER SURVIVORS: RESULTS FROM A NATIONAL SURVEY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.